NorthRock Partners LLC boosted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 7.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,882 shares of the biopharmaceutical company’s stock after acquiring an additional 664 shares during the […]